Ibaraki, Japan

Katsuhiko Ishihara


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 282 
 
Santen Pharmaceutical Co., Ltd.
 patents
silverMedal1 out of 832,880 
Other
 patents
where one patent can have more than one assignee

Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Katsuhiko Ishihara

Introduction

Katsuhiko Ishihara, based in Ibaraki, Japan, is a notable inventor recognized for his groundbreaking work in the biomedical field. With a focus on the IL-6 family cytokine receptors, Ishihara has made significant contributions aimed at developing methods to prevent or treat diseases associated with receptor malfunctions.

Latest Patents

Ishihara holds a patent for a method of screening for substances that prevent or treat diseases linked to the malfunction of IL-6 family cytokine receptors. This invention involves using a transgenic mouse or part thereof that expresses a gp130 variant. The gp130 variant may include a substitution or a deletion of a tyrosine residue corresponding to position 759 of the human gp130 protein, or a substitution, insertion, or deletion of one or more amino acid residues within the region that includes this critical tyrosine residue. This innovative approach paves the way for advancements in medical research and therapeutic interventions.

Career Highlights

Throughout his career, Katsuhiko Ishihara has been associated with various organizations, including Santen Pharmaceutical Co., Ltd. His dedication to research and innovation in the pharmaceutical sector has positioned him as a respected figure in the field of cytokine research.

Collaborations

Ishihara has collaborated with notable colleagues, including Toshio Hirano and Masahiko Hibi. These partnerships have facilitated the exchange of ideas and furthered the advancement of research relating to cytokine receptors, emphasizing the importance of teamwork in scientific discovery.

Conclusion

Katsuhiko Ishihara exemplifies the spirit of innovation through his contributions to the understanding of IL-6 family cytokine receptor malfunctions and their implications in disease treatment. His patented method represents a significant step forward in the biomedical field, showcasing how dedicated inventors can impact health and medicine profoundly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…